New Users of Metformin Are at Low Risk of Incident Cancer

2009983 citationsJournal Articlehybrid Open Access

Authors

Gillian Libby · University of Dundee

Louise A. Donnelly · University of Dundee

Peter T. Donnan · University of Dundee

Dario R. Alessi · University of Dundee

Andrew D. Morris

Josie Evans · University of Dundee

Abstract

These results suggest that metformin use may be associated with a reduced risk of cancer. A randomized trial is needed to assess whether metformin is protective in a population at high risk for cancer.

Topics & Keywords

Metabolism, Diabetes, and Cancer Diabetes Treatment and Management Cancer-related Molecular Pathways

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Diabetes Care

Volume 32, Issue 9, pp. 1620-1625

DOI: 10.2337/dc08-2175

Field-Weighted Citation Impact: 32.66